BR8605053A - Processos para a preparacao de um polipeptidio,para a preparacao de um gene sintetico,para a preparacao de um vetor de expressao,para a preparacao de um transformante bacteriano,para a determinacao de anticorpos e de virus,para a preparacao de vacina,vacinas,anticorpos,polipeptidos,gene,vetor,transformante,kit de teste - Google Patents

Processos para a preparacao de um polipeptidio,para a preparacao de um gene sintetico,para a preparacao de um vetor de expressao,para a preparacao de um transformante bacteriano,para a determinacao de anticorpos e de virus,para a preparacao de vacina,vacinas,anticorpos,polipeptidos,gene,vetor,transformante,kit de teste

Info

Publication number
BR8605053A
BR8605053A BR8605053A BR8605053A BR8605053A BR 8605053 A BR8605053 A BR 8605053A BR 8605053 A BR8605053 A BR 8605053A BR 8605053 A BR8605053 A BR 8605053A BR 8605053 A BR8605053 A BR 8605053A
Authority
BR
Brazil
Prior art keywords
preparation
antibodies
transformant
gene
vector
Prior art date
Application number
BR8605053A
Other languages
English (en)
Inventor
Wilhelm Bannwarth
Ulrich Certa
Jan Mous
Dietrich Stueber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR8605053A publication Critical patent/BR8605053A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR8605053A 1985-10-17 1986-10-16 Processos para a preparacao de um polipeptidio,para a preparacao de um gene sintetico,para a preparacao de um vetor de expressao,para a preparacao de um transformante bacteriano,para a determinacao de anticorpos e de virus,para a preparacao de vacina,vacinas,anticorpos,polipeptidos,gene,vetor,transformante,kit de teste BR8605053A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525615A GB8525615D0 (en) 1985-10-17 1985-10-17 Polypeptides

Publications (1)

Publication Number Publication Date
BR8605053A true BR8605053A (pt) 1987-07-14

Family

ID=10586812

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8605053A BR8605053A (pt) 1985-10-17 1986-10-16 Processos para a preparacao de um polipeptidio,para a preparacao de um gene sintetico,para a preparacao de um vetor de expressao,para a preparacao de um transformante bacteriano,para a determinacao de anticorpos e de virus,para a preparacao de vacina,vacinas,anticorpos,polipeptidos,gene,vetor,transformante,kit de teste

Country Status (11)

Country Link
EP (1) EP0219106A3 (pt)
JP (1) JPS6299398A (pt)
AU (1) AU602315B2 (pt)
BR (1) BR8605053A (pt)
DK (1) DK496486A (pt)
ES (7) ES2009210A6 (pt)
GB (1) GB8525615D0 (pt)
IL (1) IL80304A0 (pt)
NO (1) NO864139L (pt)
NZ (1) NZ217895A (pt)
ZA (1) ZA867748B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76082A (en) * 1984-08-22 1991-07-18 Us Health Molecular clones of the genome of htlv-iii and a process for the preparation thereof
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
DE3789633T2 (de) * 1986-05-27 1994-08-04 Hoffmann La Roche HTLV-III(LAV)Decke-Peptide.
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (en) * 1987-12-24 1990-07-25 The University Of Melbourne Antiviral compounds and methods
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6218102B1 (en) * 1988-01-27 2001-04-17 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
SE8802176D0 (sv) * 1988-06-10 1988-06-10 Kabigen Ab Fusion protein and its use
AU629237B2 (en) * 1988-08-30 1992-10-01 Applied Research Systems Ars Holding N.V. Recombinant fusion proteins for altering hormone secretion
DE68921034D1 (de) * 1988-09-27 1995-03-23 Dana Farber Cancer Inst Inc Vektor, der ein replikationskompetentes HIV-I-Provirus und ein heterologes Gen enthält.
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
EP0645454A3 (en) * 1993-06-22 1997-01-15 Vladimir Glebovich Lunin Protein containing a chimeric somatostatin, coding DNA, immunogenic compositions, and method for improving the productivity of farmes animals.
IT1271486B (it) * 1993-10-12 1997-05-28 Italfarmaco Spa Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
FR2732346B1 (fr) * 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
CA2288869A1 (en) * 1998-03-04 1999-09-10 Mary Ann Childs Rapid confirmatory test for microbial infections
ATE508139T1 (de) 2003-04-11 2011-05-15 Pasteur Institut Synthetische peptid-hiv-vakzine: das cbd-epitop als effizientes immunogen zur induktion hiv- neutralisierender antikörper
CN103356636A (zh) 2004-05-23 2013-10-23 杰勒德·M·豪斯 Theramutein调节剂
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
EP0201540B2 (en) * 1984-10-18 2001-10-31 Institut Pasteur Envelope antigens of lymphadenopathy associated virus and their applications
AU600658B2 (en) * 1984-12-24 1990-08-23 Genentech Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
DE3650175T3 (de) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules Synthetische antigene zum nachweis von aids.

Also Published As

Publication number Publication date
EP0219106A3 (en) 1989-02-08
GB8525615D0 (en) 1985-11-20
EP0219106A2 (en) 1987-04-22
ES2009907A6 (es) 1989-10-16
ES2006925A6 (es) 1989-05-16
ES2009210A6 (es) 1989-09-16
AU602315B2 (en) 1990-10-11
ES2009905A6 (es) 1989-10-16
DK496486A (da) 1987-04-18
NO864139D0 (no) 1986-10-16
NZ217895A (en) 1991-05-28
ZA867748B (en) 1987-07-29
NO864139L (no) 1987-04-21
AU6399786A (en) 1987-04-30
JPS6299398A (ja) 1987-05-08
IL80304A0 (en) 1987-01-30
ES2009906A6 (es) 1989-10-16
ES2014527A6 (es) 1990-07-16
DK496486D0 (da) 1986-10-16
ES2010538A6 (es) 1989-11-16

Similar Documents

Publication Publication Date Title
BR8605053A (pt) Processos para a preparacao de um polipeptidio,para a preparacao de um gene sintetico,para a preparacao de um vetor de expressao,para a preparacao de um transformante bacteriano,para a determinacao de anticorpos e de virus,para a preparacao de vacina,vacinas,anticorpos,polipeptidos,gene,vetor,transformante,kit de teste
BR8701528A (pt) Proteina,sequencia de dna,vetor recombinante,organismo celular,processos para producao de uma proteina e para a preparacao de um organismo unicelular,processos para a deteccao da presenca de anticorpos e de virus de aids,processos para a preparacao de uma vacina e para a preparacao de anticorpos,formulacao de vacina,anticorpos,uso,vacina,kit de teste e metodo para a prevencao de aids
DK521386A (da) Fremgangsmaade til bestemmelse af aminosyre-sekvensen af et polypeptid, som er komplementaert til et peptid eller protein eller en del heraf, samt middel til brug ved fremgangsmaaden
DK374087D0 (da) Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne
PT90574A (pt) Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma
ES551113A0 (es) Procedimiento para preparar peptidos trifluormetilcetona-sustituidos.
DK375283A (da) Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmaader til fremstilling af kvaegvaeksthormonlignende polypeptider
DK164529C (da) Fremgangsmaade til paavisning eller bestemmelse af et peptid indeholdende en sekvens af aminosyrer, som er antigenaktiv
AR243080A1 (es) Procedimiento para obtener un complejo inmunogenico entre proteinas antigenicas o peptidos con regiones hidrofobas y bisdesmosidos con regiones hidrofobas.
ATE87655T1 (de) Markierer der t-zelle aktivierung.
DK516583D0 (da) Tricycliske aminosyrer eller salte deraf,deres fremstilling og anvendelse samt mellemprodukter og disses fremstilling
GB8501473D0 (en) Cloned dna sequences
DE3686100D1 (de) Apparat zur pruefung von objekten.
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
JPH02500022U (pt)
DK457687A (da) Antigenisk aktive proteiner og peptider, og vacciner mod virus for felin peritonitis (fipv) med indhold af saadanne proteiner eller peptider
DK162929C (da) Mappe eller lignende samt fremgangsmaade og apparat til fremstilling heraf
FI101797B1 (fi) STLV-III-virukseen liittyvät polypeptidit, diagnostiset järjestelmät ja määritysmenetelmät
NO922421L (no) Collagenbindende protein, samt fremstilling derav
ES2194012T3 (es) Epitopo p1a1 y p1a2 de la gpiii a de plaquetas, su preparacion y uso.
NO892269D0 (no) Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
FI870501A (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
DE3682105D1 (de) Probe, tracers, immunogene und antikoerper von ethosuximid.
IL106592A0 (en) Peptides,analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus